LabSimply
LabSimply, based in Urbana, IL, is a healthcare diagnostics company focusing on developing CRISPR enzyme-based point-of-care tests aimed at replacing low accuracy tests in the U.S. and Canada.
Company Overview
LabSimply, formerly known as Labsimply, Inc., is a healthcare company based in Urbana, IL, USA. Specializing in healthcare diagnostics, LabSimply is dedicated to advancing the field through innovative solutions. The team comprises 4 members and focuses on developing point-of-care tests using novel CRISPR enzymes. The company aims to significantly improve the accuracy and speed of diagnostic testing in the United States.
Regions Served
LabSimply primarily serves regions in the United States of America and Canada. With a strong focus on these regions, the company is committed to enhancing the diagnostic landscape by offering improved testing accuracy and faster results. Through its innovative solutions, LabSimply aims to address the pressing need for reliable and quick diagnostic tests in these areas.
Y Combinator Involvement
LabSimply is a part of the prestigious Y Combinator program, having been included in the S21 batch. Y Combinator is renowned for supporting startups with high potential in various industries, and LabSimply’s inclusion in the S21 batch highlights its promise and innovative approach in the field of healthcare diagnostics. Being part of this program provides LabSimply with access to a vast network of resources and mentorship to drive its growth and development.
Innovative Diagnostic Solutions
LabSimply focuses on developing point-of-care tests utilizing novel CRISPR enzymes. This groundbreaking technology aims to replace over 70 million low accuracy tests annually in the US with tests that offer PCR-level accuracy and deliver results in 5 minutes or less. By leveraging this advanced technology, LabSimply seeks to revolutionize the diagnostic process, providing faster and more reliable results for patients and healthcare providers.
